Article Details

Junshi Biosciences Receives NMPA Approval of sNDA for Toripalimab in Combination with ...

Retrieved on: 2022-09-20 18:16:13

Tags for this article:

Click the tags to see associated articles and topics

Junshi Biosciences Receives NMPA Approval of sNDA for Toripalimab in Combination with .... View article details on HISWAI: https://financialpost.com/globe-newswire/junshi-biosciences-receives-nmpa-approval-of-snda-for-toripalimab-in-combination-with-chemotherapy-as-first-line-treatment-for-advanced-non-squamous-non-small-cell-lung-cancer

Excerpt

Its first-in-human anti-BTLA monoclonal antibody for the treatment of various cancers was the first in the world to be approved for clinical trials by ...

Article found on: financialpost.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up